• Ambrisentan (Par Pharmaceutical)
Ambrisentan film-coated tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability and delay clinical worsening. Studies establishing effectiveness included predominantly patients with WHO Functional Class II–III symptoms and etiologies of idiopathic or heritable PAH (60%) or PAH associated with connective tissue diseases (34%). It is supplied in 5 mg and 10 mg tablet strengths and is available in the following package configurations: 5 mg 10 count bottle, 5 mg 30 count bottle, 10 mg 10 count bottle and 10 mg 30 count bottle.
For more information about Ambrisentan, log in to biosupply.fffenterprises.com
• Bosentan (Par Pharmaceutical)
Bosentan tablet is an endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in adults to improve exercise ability and to decrease clinical worsening. Studies establishing effectiveness included predominantly patients with WHO Functional Class II-IV symptoms and etiologies of idiopathic or heritable PAH (60%), PAH associated with connective tissue diseases (21%), and PAH associated with congenital heart disease with left-to-right shunts (18%). It is available as a 62.5 mg tablet in a bottle containing 60 tablets and a 125 mg tablet in a bottle containing 60 tablets.
For more information about Bosentan, log in to biosupply.fffenterprises.com
• Treprostinil (Par Pharmaceutical)
Treprostinil injection is a prostacyclin vasodilator indicated for pulmonary arterial hypertension (PAH) and pulmonary arterial hypertension in patients requiring transition from epoprostenol. It is supplied in 20 mL multidose vials as sterile solutions in water for injection, individually packaged in cartons, and is available in 1 mg/mL, 2.5 mg/mL, 5 mg/mL and 10 mg/mL concentrations.
For more information about Treprostinil, log in to biosupply.fffenterprises.com
• KOATE (Kedrion)
KOATE is indicated for the treatment of hemophilia A in which there is a demonstrated deficiency of activity of clotting factor VIII. Koate provides a means of temporarily replacing the missing clotting factor to control or prevent bleeding episodes, or to perform emergency and elective surgery on individuals with hemophilia. It is supplied in a kit containing one single-use vial of Koate lyophilized powder, one vial of sterile water for injection, USP, one sterile double-ended transfer needle, one sterile filter needle, and one sterile administration set.
For more information about KOATE, log in to biosupply.fffenterprises.com
• ELCYS (EXELA PHARMA SCIENCES)
ELCYS (cysteine hydrochloride injection) is indicated for use as an additive to amino acid solutions to meet the nutritional requirements of newborn infants requiring total parenteral nutrition (TPN) and of adult and pediatric patients with severe liver disease who may have impaired enzymatic processes and require TPN. Each 10 mL of ELCYS contains 500 mg of cysteine hydrochloride, USP (equivalent to 345 mg of cysteine) in water for injection. Sodium hydroxide and/or hydrochloric acid are used as needed to adjust the pH range from 1.0 to 2.5.
For more information about ELCYS, log in to biosupply.fffenterprises.com
• CEFTAZIDIME USP AND DEXTROSE USP (B. BRAUN MEDICAL INC.)
CEFTAZIDIME for injection USP and DEXTROSE injection USP are cephalosporin antibacterials indicated for treatment of the following infections caused by susceptible isolates of the designated microorganisms: lower respiratory tract infections, skin and skin-structure infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra-abdominal infections and central nervous system infections. They are supplied in 1 gram in 50 mL and 2 grams in 50 mL DUPLEX containers.
For more information about CEFTAZIMIDE and DEXTROSE, log in to biosupply.fffenterprises.com
• CEFTRIAXONE AND DEXTROSE (B. BRAUN MEDICAL INC.)
Ceftriaxone for injection and Dextrose injection are cephalosporin antibacterials indicated for treatment of the following infections caused by susceptible isolates of the designated bacteria: lower respiratory tract infections, skin and skin structure infections, complicated and uncomplicated urinary tract infections, pelvic inflammatory disease, bacterial septicemia, bone and joint infections, intra-abdominal infections, meningitis and surgical prophylaxis. They should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. Both are supplied in dual chamber, single-use containers consisting of 1 gram ceftriaxone for injection and 50 mL of 3.74% dextrose injection; and 2 grams ceftriaxone for injection and 50 mL of 2.22% dextrose injection.
For more information about CEFTRIAXONE and DEXTROSE, log in to biosupply.fffenterprises.com
• CEFOTETAN AND DEXTROSE (B. BRAUN MEDICAL INC.)
CEFOTETAN for injection USP and DEXTROSE injection USP is indicated for therapeutic treatment of the following infections when caused by susceptible strains of the designated organisms (see prescribing information): 1) urinary tract infections, 2) lower respiratory tract infections, 3) skin and skin structure infections, 4) gynecologic infections, 5) intra-abdominal infections and 6) bone and joint infections. They are supplied as a sterile, nonpyrogenic, single use packaged combination of Cefotetan disodium and Dextrose injection (diluent) in the DUPLEX sterile container.
For more information about CEFOTETAN AND DEXTROSE, log in to biosupply.fffenterprises.com
• MEROPENEM AND SODIUM CHLORIDE (B. BRAUN MEDICAL INC.)
MEROPENEM for injection USP and SODIUM CHLORIDE injection USP is a penem antibacterial indicated as single agent therapy for the treatment of complicated skin and skin structure infections (adult patients and pediatric patients 3 months of age and older requiring the full adult dose only); complicated intra-abdominal infections (adult patients and pediatric patients 3 months of age and older requiring the full adult dose only); and bacterial meningitis (pediatric patients 3 months of age and older requiring the full adult dose only). They are supplied as 500 mg Meropenem for injection USP and 50 mL sodium chloride injection 0.9% USP, and 1 gram Meropenem for injection USP and 50 mL sodium chloride injection 0.9% USP in DUPLEX containers.
For more information about MEROPENEM AND SODIUM CHLORIDE, log in to biosupply.fffenterprises.com
These products can be ordered from FFF Enterprise's BioSupply Online Ordering System or by calling
Wow! Customer Care at (800) 843-7477.
|
